UPDATE: NxStage Medical CEO on its Wall-Street-beating Q4 results

February 28, 2013 by MassDevice staff

NxStage Medical founder & CEO Jeff Burbank tells MassDevice.com about its 4th-quarter and 2012 results, which topped Wall Street forecasts today, sending share prices up nearly 8% at their peak.

NxStage  press release

NxStage Medical (NSDQ:NXTM) shares jumped nearly 8% today after the medical device company reported Wall-Street-beating results for the 4th quarter and 2012.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.